Andrew Rogan - Profile and Investment Details

Investor Profile

Andrew Rogan is a Venture Capital based in Cambridge, England, United Kingdom with a diverse investment portfolio that includes companies such as Closed Loop Medicine, Nu Quantum, IQ Capital, Porotech, Funderbeam, Thought Machine, Spectral Edge, Nyobolt, NeulMyrtle Software, TurinTech, Apperio, MQube, Opteran, Oxford Space Systems, Iotic, Sirigen, Privitar, AccelerComm, Pangaea Data, Stillfront Group, Rosslyn Data Technologies PLC, Cambridge GaN Devices, Grapeshot, Spikes Cavell & Co, Phonetic Arts, Divido, miiCard, Digital Assess, CyberSmart, Cambridge Communication Systems, Wluper, The ID Co., CybSafe, Speechmatics, Concirrus, Senseye, Unbound, Focal Point Positioning, causaLens, Audio Analytic, Bloomsbury AI, Synthesized, FNA, BioBeats, KisanHub, Paragraf, Focal Point Data Risk, Dataswift, Desktop Genetics, BMLL Technologies, Imandra, Fluidic Analytics, Optellum, Neurovalens, ChargePoint Services, TOffeeAM, . Over time, Andrew Rogan has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Andrew Rogan is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Cybersecurity, Enterprise Software, Banking, Artificial Intelligence (AI), Information Technology (IT), Analytics, Software, Manufacturing, Groceries, FinTech, Agriculture, Hardware, Renewable Energy, Medical, SaaS, Battery, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Andrew Rogan, as their portfolio suggests a familiarity and interest in this area.

Understanding Andrew Rogan’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.